Evidence map›Paper›PMID 30998646›Full record

ArticleShock (Augusta, Ga.)2020

Selenium and Selenoprotein P Deficiency Correlates With Complications and Adverse Outcome After Major Trauma.

Mareen Braunstein, Thomas Kusmenkov, Catrin Zuck, Matthias Angstwurm, Niels-Peter Becker, Wolfgang Böcker, Lutz Schomburg, Viktoria Bogner-Flatz

Open access · hybridAbstract read
In one paragraph

Article in Shock (Augusta, Ga.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mareen BraunsteinDepartment of Trauma Surgery, University Hospital Munich, Ludwig-Maximilians-University, Munich, Germany.
Thomas KusmenkovDepartment of Trauma Surgery, University Hospital Munich, Ludwig-Maximilians-University, Munich, Germany.
Catrin ZuckDepartment of Trauma Surgery, University Hospital Munich, Ludwig-Maximilians-University, Munich, Germany.
Matthias AngstwurmDivision of Respiratory Medicine and Thoracic Oncology, Department of Internal Medicine V, University of Munich (LMU), Munich, Germany.
Niels-Peter BeckerInstitute for Experimental Endocrinology, Charité-University Medicine Berlin, Berlin, Germany.
Wolfgang BöckerDepartment of Trauma Surgery, University Hospital Munich, Ludwig-Maximilians-University, Munich, Germany.
Lutz SchomburgInstitute for Experimental Endocrinology, Charité-University Medicine Berlin, Berlin, Germany.
Viktoria Bogner-FlatzDepartment of Trauma Surgery, University Hospital Munich, Ludwig-Maximilians-University, Munich, Germany.
Ludwig-Maximilians-Universität München · DECharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA declining selenium (Se) status constitutes a characteristic of critical illness and may affect disease course and survival. The dynamics of trauma-induced changes in biomarkers of Se status are poorly characterized, and an association with multiple organ failure (MOF) and mortality can be hypothesized. It was the aim of this study to investigate Se and selenoprotein P (SELENOP) concentrations in major trauma patients during the early posttraumatic period. PATIENTS AND

methodsTwenty-four patients after major trauma (ISS ≥16) were included at our level one trauma center. Se supplementation ever during the 90-day observation period was defined as an exclusion criterion. Serum samples were drawn within less than 60 min after trauma, and after 6 h, 12 h, 24 h, 48 h, and 72 h. Serum Se was analyzed by X-ray fluorescence and SELENOP concentrations by ELISA. The data were correlated to clinical parameters, occurrence of MOF defined by MOF and APACHE II score, lung injury defined by Horowitz index and clinical outcome (90-days survival).

resultsSerum Se and SELENOP concentrations of the trauma patients were significantly below the average of healthy European subjects (mean ±SD; Se, 41.2±8.1 vs. 84.7±23.3 μg/L, P < 0.001; SePP, 1.5±0.3 vs. 4.3±1.0 mg/L, P < 0.001). A strong deficit was present already at the first time point (Se; 33.6±10.5 μg/L, SELENOP: 1.4±0.5 mg/L). The clinical scores collectively showed an inverse relation between health status and Se biomarkers. Patients who did not survive the 90-day observation period exhibited significantly lower initial post-trauma Se status than the surviving patients (mean±SD; Se, 24.7±7.2 vs. 39.2±8.4 μg/L, P<0.05; SePP, 1.1±0.4 vs. 1.6±0.4 mg/L, P<0.05).

conclusionVery low Se and SELENOP concentrations occur fast after major trauma and are associated with poor survival odds. These findings support the notion that early Se substitution may constitute a meaningful adjuvant treatment strategy in trauma patients.

Indexed as

AdultAgedAged, 80 and overAPACHEBiomarkersFemaleHumansMaleMiddle AgedProspective StudiesSeleniumSelenoprotein PWounds and InjuriesYoung AdultBiomarkersSeleniumSelenoprotein P

Identifiers

PMID30998646
PMCPMC6919221
OpenAlexW2942317086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.